Strahlentherapie des regionären Lymphabflusses bei malignen Tumoren des Kofs-Hals-Bereiches

  • S. Staar


Die perkutane Strahlentherapie ist neben den unterschiedlichen chirurgischen Ansätzen der zervikalen Lymphknotenausräumung die wichigste onkologische Modalität in der Behandlung zervikaler Lymphknotenmetastasen. Der Einsatz einer Radiotherapie wird wesentlich durch den Primärtumor, seine Ausdehnung und Lokalisation, Zelltyp und Vorliegen regionärer Lymphknotenmetastasen wie auch Art und Ausmaß der vorangegangenen oder geplanten chirurgischen Intervention bestimmt.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Adelstein DJ, Adams GL, Li Y et al. Eastern Cooperative Oncology Group (2000) A phase III comparison of standard radiation therapy (RT) versus RT plus concurrent cisplatin (DDP) versus split-course RT plus concurrent DDP and 5-Fluorouracil (5-FU) in patients with unresectable squamous cell head and neck cancer (SCHNC): An Intergroup Study. Proc Am Soc Clin Oncol 19: abstr 1624Google Scholar
  2. 2.
    Ain KB (1999) Anaplastic thyroid carcinoma: A therapeutic challenge. Semin Surg Oncol 16: 64–69PubMedCrossRefGoogle Scholar
  3. 3.
    Al-Sarraf M, Pajak TF, Byhardt RW, Beitler JJ, Salter MM, Cooper JS (1997) Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88–24. Int J Radiat Oncol Biol Phys 37: 777–782PubMedCrossRefGoogle Scholar
  4. 4.
    Ang KK, Byers RM, Peters LJ et al. (1990) Regional radiotherapy as adjuvant treatment for head and neck malignant melanoma. Preliminary results. Arch Otolaryngol Head Neck Surg 116: 169–172PubMedCrossRefGoogle Scholar
  5. 5.
    Ang KK, Trotti A, Garden A et al. (1998) Importance of overall time factor in postoperative radiotherapy. Proceedings of the 4th International Conference on Head and Neck Cancer, TorontoGoogle Scholar
  6. 6.
    Armstrong JG, Harison LB, Thaler HAT et al. (1991) The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer 69: 615–619CrossRefGoogle Scholar
  7. 7.
    Bachaud JM, David JM, Boussin G, Daly N (1991) Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: Preliminary report of a randomised trial. Int J Radiat Oncol Biol Phys 20: 243–246PubMedCrossRefGoogle Scholar
  8. 8.
    Becker A, Büchele T, Schöber C et al. (1998) Zweitbestrahlungvon Plattenepithelkarzinomen im HNO-Bereich in simultaner Kombination mit Paclitaxel zweimal wöchentlich. Strahlenther Onkol 174 (Suppl 1): 9–14Google Scholar
  9. 9.
    Bourhis J, Lapeyre M, Tortochaux et al. (2000) Very accelerated versus conventional radiotherapy in HNSCC: Results of the GORTEC 94–02 randomized trial. Int J Radiat Oncol Biol Phys 48 (Suppl) abstr 2Google Scholar
  10. 10.
    Boyle F, Pendelbury S, Bell D (1995) Further insights into the natural history and management of cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biol Phys 15: 315–323CrossRefGoogle Scholar
  11. 11.
    Brierley J, Tsang R, Simpson WJ, Gospodarowicz M, Sutcliffe S, Panzarella T (1996) Medullary thyroid cancer: Analyses of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 6: 305–310PubMedCrossRefGoogle Scholar
  12. 12.
    Brierley JD, Tsang RW (1999) External-beam radiation therapy in the treatment of differentiated thyroid cancer. Semin Surg Oncol 16: 42–49PubMedCrossRefGoogle Scholar
  13. 13.
    Brizel DM, Alsbers M, Fisher S (1998) Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338: 1798–1804PubMedCrossRefGoogle Scholar
  14. 14.
    Brockstein B, Haraf DJ, Kies M et al. (2000) Distant metastases (DM) after concomitant chemoradiotherapy (CRT) for head and neck cancer (HNC): Risk is dependent upon pretreatment lymph node (LN) stage. Proc Am Soc Clin Oncol 19: 414, abstr 1635Google Scholar
  15. 15.
    Browman GP, Cripps C, Hodson DI et al. (1994) Placebo-controlled randomized trail of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol 12: 2648–2653PubMedGoogle Scholar
  16. 16.
    Brunin F, Rodriguez J, Jaullery C (1989) Induction chemotherapy in advanced head and neck cancer. Acta Oncol 28: 61–65PubMedCrossRefGoogle Scholar
  17. 17.
    Budach VG, Dinges S, Haake K et al. (2000) Accelerated chemoradiation to 70.6 Gy is more effective than accelerated radiation to 77.6 Gy alone - two years results of a German multicenter randomized trial. Int J Radiat Oncol Biol Phys 48 (Suppl) abstr 78Google Scholar
  18. 18.
    Burmeister BH, Poulsen MG, Smithers BM (1997) Radiation therapy following nodal dissection for malignant melanoma. Report on an phase II study. Melanoma Res 1: 18–19CrossRefGoogle Scholar
  19. 19.
    Calais G, Alfonsi M, Bardet E et al. (1999) Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carinoma. J Natl Cancer Inst 91: 2081–2086PubMedCrossRefGoogle Scholar
  20. 20.
    Calearo C, Pastore A, Storchi OF, Polli G (1998) Parotid gland carcinoma: Analysis of prognostic factors. Ann Otol Rhinol Laryngol 107: 969–973PubMedGoogle Scholar
  21. 21.
    Creagan ET, Cupps RE, Ivins JC et al. (1978) Adjuvant radiation therapy for regional nodal metastases from malignant melanoma. A randomized, prospective study. Cancer 42: 2206–2210PubMedCrossRefGoogle Scholar
  22. 22.
    Crevoisier de R, Bourhis J, Domenge P et al. (1998) Full-dose reirradiation for unresectable head and neck carcinoma: Experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol 16: 3556–3562PubMedGoogle Scholar
  23. 23.
    Dagum P, Pinto HA, Newman J et al. (1998) Management of the clinically positive neck in organ preservation for advanced head and neck cancer. Am J Surg 176: 448–452PubMedCrossRefGoogle Scholar
  24. 24.
    Depondt J, Gehanno P, Martin M (1993) Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer. Oncology 50: 23–27PubMedCrossRefGoogle Scholar
  25. 25.
    DeSanto LW, Beahrs OH, Holt JJ, O’Fallon WM (1985) Neck dissection and combined therapy. Study of effectiveness. Arch Otolaryngol 111: 366–379PubMedCrossRefGoogle Scholar
  26. 26.
    Dische S, Saunders M, Barrett A et al. (1997) A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 44: 123–136PubMedCrossRefGoogle Scholar
  27. 27.
    Dobrowsky W, Naude J (2000) Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers. Radiother Oncol 57: 119–124PubMedCrossRefGoogle Scholar
  28. 28.
    Eifel PJ, McClure S (1989) Severe chemotherapy-induced recall of radiation mucositis in a patient with non-Hodgkin lymphoma of Waldeyer’s ring. Int J Radiat Oncol Biol Phys 17: 907–909PubMedCrossRefGoogle Scholar
  29. 29.
    Farahati J, Reiners C, Stuschke M et al. (1996) Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage T4). Cancer 77: 172–180PubMedCrossRefGoogle Scholar
  30. 30.
    Feldmann HJ, Budach V, Budach W, Molls M, Sack H (1991) Postoperative Strahlenbehandlung der Speicheldrüsentumoren. Strahlenther Onkol 167: 261–266PubMedGoogle Scholar
  31. 31.
    Fife KM, Bower M, Harmer CL (1996) Medullary thyroid cancer: The role of radiotherapy in local control. Eur J Surg Oncol 22: 588–591PubMedCrossRefGoogle Scholar
  32. 32.
    Fletcher GH (1980) Textbook of Radiotherapy, 3rd edn. Lea & Febiger, PhiladelphiaGoogle Scholar
  33. 33.
    Fu KK, Pajak TF, Trotti A et al. (1999) A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: Preliminary results of RTOG 9003. Int J Radiat Oncol Biol Phys 45: 145 abstr 1CrossRefGoogle Scholar
  34. 34.
    Garbe C, Dummer R, Kaufmann R, Tilgen W (Hrsg) (1997) Dermatologische Onkologie. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  35. 35.
    Garden AS, Weber RS, Ang KK, Morrison WH, Matre J, Peters LJ (1994) Postoperative radiation therapy for malignant tumors of minor salivary glands: Outcome and patterns of failure. Cancer 73: 2563–2569PubMedCrossRefGoogle Scholar
  36. 36.
    Garden AS, Weber RS, Morrison WH, Ang KK, Peters LJ (1995) The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys 32: 619–626PubMedCrossRefGoogle Scholar
  37. 37.
    Goepfert H, Remmler D, Silva E, Wheeler B (1984) Merkel cellcarcinoma (endocrine carcinoma of the skin) of the head and neck. Arch Otolaryngol 110: 707–712PubMedCrossRefGoogle Scholar
  38. 38.
    Haag ML, Glass IF, Fenske NA (1995) Merkel cell carcinoma. Diagnosis and treatment. Dermatol Surg 21: 669–683PubMedCrossRefGoogle Scholar
  39. 39.
    Haffty BG, Son YH, Sasaki CT et al. (1993) Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: Results from two randomized clinical trials. Int J Radiat Oncol Biol Phys 27: 241–250PubMedCrossRefGoogle Scholar
  40. 40.
    Haraf DJ, Weichselbaum RR, Vokes EE (1996) Reirradiation with concomitant chemotherapy of unresectable recurrent . head and neck cancer: A potentially curable disease. Ann Oncol 7: 913–918PubMedCrossRefGoogle Scholar
  41. 41.
    Harmer C, Bidmead M, Shepherd S, Sharpe A, Vini L (1998) Radiotherapy planning techniques for thyroid cancer. Br J Radiol 71: 1069–1075PubMedGoogle Scholar
  42. 42.
    Haselow RE, Warshaw MC, Oken MM et al. (1990) Radiation alone versus radiation with weekly low-dose cis-platinum in unresectable cancer of the head and neck. In: Fee WE Jr, Goepfert H, Johns B et al. (eds) Head and neck cancer, vol 2. Decker, Philadelphia, pp 279–281Google Scholar
  43. 43.
    Holmes S (1986) Radiotherapy: minimizing the side effects. Professional Nurse 1, 10: 263–266Google Scholar
  44. 44.
    Jeremic B, Shibamoto Y, Stanisavljevic B et al. (1997) Radiaion therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: A prospec tive randomized trial. Radiother Oncol 43: 29–37PubMedCrossRefGoogle Scholar
  45. 45.
    Kish JA, Benedetti JK, Balcerzak SP et al. (1999) Feasibility trial of postoperative radiotherapy and cisplatin followed by three courses of 5-FU and cisplatin in patients with resected head and neck cancer: A Southwest Oncology Group study. Cancer J Sci Am 5: 307–311PubMedGoogle Scholar
  46. 46.
    Le QT, Birdwell S, Terris DJ et al. (1999) Postoperative irradiation of minor salivary gland malignancies of the head and neck. Radiother Oncol 52: 165–171PubMedCrossRefGoogle Scholar
  47. 47.
    Lerch H, Schober O, Kuwert T, Saur HB (1997) Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 15: 2067–2075PubMedGoogle Scholar
  48. 48.
    Levendag PC, Nowak PJCM, van der Sangen MJC et al. (1996) Local tumor control in radiation therapy of cancers in the head and neck. Am J Clin Oncol 19: 469–477PubMedCrossRefGoogle Scholar
  49. 49.
    Lin JD, Tsang NM, Huang MJ, Wenig HF (1997) Results of external beam radiotherapy in patients with well differentiated thyroid carcinoma. Jpn J Clin Oncol 27: 244–247PubMedCrossRefGoogle Scholar
  50. 50.
    Little J (1996) Head and neck cancer: Oral care during radiotherapy. Nursing Standard 10, 22: 39–42Google Scholar
  51. 51.
    Lundahl RE, Foote RL, Bonner JA et al. (1998) Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck. A matched-pair analysis. Int J Radiat Oncol Biol Phys 40: 529–534PubMedCrossRefGoogle Scholar
  52. 52.
    MacComb WS, Fletcher GH (1957) Planned combination of surgery and radiation in treatment of advanced primary head and neck cancer. AJR Am J Roentgenol 77: 397–415Google Scholar
  53. 53.
    Magnano M, Bongioannini G, Lerda W et al. (1999) Lymphnode metastasis in head and neck squamous cells carcinoma: Multivariate analysis of prognostic variables. J Exp Clin Cancer Res 18: 79–83PubMedGoogle Scholar
  54. 54.
    Magnano M, Gervasio CF, Cravero L et al. (1999) Treatment of malignant neoplasm of the parotid gland. Otolaryngol Head Neck Surg 121: 627–632PubMedCrossRefGoogle Scholar
  55. 55.
    Meeuwissen JA, Bourne RG, Kearsley JH (1994) The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 31: 325–331CrossRefGoogle Scholar
  56. 56.
    Million RR, Cassisi NJ (1994) (eds) Management of head and neck cancer, 2nd edn. Lippincott, Philadelphia,PP 711–735Google Scholar
  57. 57.
    Mohr C, Bohndorf W, Carstens J et al. (1994) Preoperative radiochemotherapy and radical surgery in comparison with surgery alone. A prospective, multicentric randomized DÖSAK study for advanced squamous cell carcinoma of the oral cavity and oropharynx (a 3-year follow-up). Int J Oral Maxillofac Surg 23: 143–148Google Scholar
  58. 58.
    Newman LA, Vieira F, Schwiezer V et al. (1998) Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 124: 589–592PubMedGoogle Scholar
  59. 59.
    Niedermeier W, Meyer C, Staar S, Mueller RP (1995) Secretion of human minor and major salivary glands following ra diotherapy. J Dent Res 74: 546Google Scholar
  60. 60.
    O’Brien CJ, Peterson-Schaefer K, Stevenson GN et al. (1997) Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic malignant melanoma. Head Neck 19: 589–594PubMedCrossRefGoogle Scholar
  61. 61.
    Paccagnella A, Orlando A, Marchlori C et al. (1993) A phase III trial of neoadjuvant chemotherapy in head and neck cancer. Proc Am Soc Clin Oncol 12: 894Google Scholar
  62. 62.
    Peters LJ, Goepfert H, Ang KK et al. (1993) Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 26: 3–11PubMedCrossRefGoogle Scholar
  63. 63.
    Pigott K, Dische S, Saunders MI (1995) Where exactly does failure occur after radiation in head and neck cancer ? Radiother Oncol 37: 17–19PubMedCrossRefGoogle Scholar
  64. 64.
    Phillips TL, Fu KK (1976) Quantification of combined radiation therapy and chemotherapy effects on critical normal tissues. Cancer 37: 1186–1200PubMedCrossRefGoogle Scholar
  65. 65.
    Phillips TL (1994) Terminology of chemoradiation effects. In: John MJ, Flam MS, Legha SS, Phillips TL (eds) Chemoradiation: An integrated approach to cancer treatment. Lea & Febinger, Philadelphia, pp 11–17Google Scholar
  66. 66.
    Puc MM, Chrzanowski FA, Tran HS et al. (2000) Preoperative chemotherapy-sensitized radiation therapy for cervical metastases in head and neck cancer. Arch Otolaryngol Head Neck Surg 126: 337–342PubMedGoogle Scholar
  67. 67.
    Ratner D, Nelson BR, Brown MD, Johnson TM (1993) Merkel cell carcinoma. J Am Acad Dermatol 29: 143–156PubMedCrossRefGoogle Scholar
  68. 68.
    Rudoltz MS, Benammar MS, Mohiuddin M (1995) Does pathologic node status affect local control in patients with carcinoma of the head and neck treated with radical surgery and postoperative radiotherapy ? Int J Radiat Oncol Biol Phys 31: 503–508PubMedCrossRefGoogle Scholar
  69. 69.
    Sadeghi A, Tran LM, Mark R, Sidrys J, Parker RG (1993) Minor salivary gland tumors of the head and neck: Treatment strategies and prognosis. Am J Clin Oncol 16: 3–8PubMedCrossRefGoogle Scholar
  70. 70.
    Salvajoli J, Morioka H, Trippe N, Kowalski A (1992) A randomized trial of neoadjuvant versus concomitant radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma. Eur Arch Otol Rhinol Laryngol 249: 211–215Google Scholar
  71. 71.
    Sanchiz F, Milla A, Torner J et al. (1990) Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int J Radiol Oncol Biol Phys 19: 1627–1628Google Scholar
  72. 72.
    Schaefer U, Micke O, Schueller P, Willich N (2000) Recurrent head and neck cancer: Retreatment of previously irradiated areas with combined chemotherapy and radiation therapy - results of a prospective study. Radiology 216: 371–376PubMedGoogle Scholar
  73. 73.
    Shaha AR (1998) Management of the neck in thyroid cancer. Otolaryngol Clin North Am 31: 823–831PubMedCrossRefGoogle Scholar
  74. 74.
    Shin DM, Lippman SM (1999) Paclitaxel based chemotherapy for recurrent and/or metastatic head and neck squa-mous-cell carcinoma: Current and future directions. Semin Oncol 26: 100–105PubMedGoogle Scholar
  75. 75.
    Staar S, Mueller RP, Walz C, Pape HD (1994) Preoperative combined simultaneous radiochemotherapy in primarily.operable advanced oropharynx carcinomas (The Cologne Concept). J Cancer Res Clin Oncol 120 (Suppl): 88Google Scholar
  76. 76.
    Staar S, Niedermeier W, Meier T, Strehl H, Mueller RP (1998) Die radiogene Xerostomie im Verlauf und nach Behandlung mit Pilokarpin. Strahlenther Onkol 174, Sonder-Nr 1:13CrossRefGoogle Scholar
  77. 77.
    Staar S, Rudat V, Dietz A et al. (2000) Hyperfractionated (HF) accelerated (ACC) radiochemotherapy (RCT) versus HF/ACC radiotherapy (RT) in advanced head and neck (HN) cancer - a multicentric randomized German trial. Proc Am Soc Clin Oncol 19: 1628Google Scholar
  78. 78.
    Steel GG, Peckham MJ (1979) Exploitable mechanisms in combined radiotherapy and chemotherapy. The concept of additivity. Int J Radiat Oncol Biol Phys 5: 85–91PubMedCrossRefGoogle Scholar
  79. 79.
    Stuschke M, Marnitz S, Wurm R, Budach V (2000) Für welche Tumorentitäten ist ein Einfluss der Gesamtbehandlungzeit auf die Ergebnisse der Strahlenbehandlung evident? Strahlenther Onkol 176: 462–465PubMedCrossRefGoogle Scholar
  80. 80.
    Suntharalingam M, Rudoltz MS, Mendenhall WM, Parsons JT, Stringer SP, Million RR (1995) Radiotherapy for Merkel cell carcinoma of the skin of the head and neck. Head Neck 17: 96–101PubMedCrossRefGoogle Scholar
  81. 81.
    Sykes AJ, Slevin NJ, Gupta NK, Brewster AE (2000) 331 cases of clinically node-negative supraglottic carcinoma of the larynx: a study of a modest size fixed field radiotherapy approach. Int J Radiat Oncol Biol Phys 46: 1109–1115PubMedCrossRefGoogle Scholar
  82. 82.
    Tannock IF (1992) Potential for therapeutic gain from combined-modality treatment. Front Radiat Ther Oncol 26: 1–15PubMedGoogle Scholar
  83. 83.
    Tejedor M, Murias A, Soria P et al. (1992) Induction chemotherapy with carboplatin and floratur in advanced head and neck cancer. A randomized study. Am J Clin Oncol 15: 417–421PubMedGoogle Scholar
  84. 84.
    Tran L, Sidrys J, Sadeghi A, Ellerbrock N, Hanson D, Parker RG (1990) Salivary gland tumors of the oral cavity. Int J Radiat Oncol Biol Phys 18: 413–417PubMedCrossRefGoogle Scholar
  85. 85.
    Trott KR (1986) Radiatio - chemotherapy interactions. Int J Radiat Oncol Biol Phys 12: 1409–1413PubMedCrossRefGoogle Scholar
  86. 86.
    Trott KR, Baumann M (2000) Welche Methoden zur Minimierung des Zeitfaktors sind gesichert, welche sind ungesichert ? Strahlenther Onkol 176: 472–474PubMedCrossRefGoogle Scholar
  87. 87.
    Trotti A (2000) Toxicity in head and neck cancer: A review of trends and issues. Int J Radiat Oncol Biol Phys 47: 1–12PubMedCrossRefGoogle Scholar
  88. 88.
    Vikram B, Strong EW, Shah JP, Spiro R (1984) Failure in the neck following multimodality treatment for advanced head and neck cancer. Head Neck Surg 6: 724–729PubMedCrossRefGoogle Scholar
  89. 89.
    Weber RS, Byers RM, Petit B, Wolf P, Ang K, Luna M (1990) Submandibular gland tumors. Adverse histologic factors and therapeutic implications. Arch Otolaryngol Head Neck Surg 16: 1055–1060CrossRefGoogle Scholar
  90. 90.
    Weissberg J, Son Y, Papac R (1989) Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys 17: 3–9PubMedCrossRefGoogle Scholar
  91. 91.
    Weissler M, Melin S, Sailer S, Qaqish BF, Rosenman JG, Pillsbury HC (1992) Simultaneous chemoradiation in the treatment of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 118: 806–810PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • S. Staar

There are no affiliations available

Personalised recommendations